Corsica Health Review

Corsica Health: the rare provider that shows you compounded and brand prices on the same screen

Most GLP-1 telehealth sites pick a lane. They either sell you a cheaper compounded copy of semaglutide or tirzepatide, or they help you get the brand-name pen. Few do both, and almost none lay the prices out next to each other. Corsica Health is the unusual exception. It publishes its compounded plans and its brand-name injections side by side on one platform, so you can see exactly what the trade-off costs before you ever fill out an intake form. If you have been bouncing between sites trying to compare a budget compounded plan against brand-name Wegovy or Mounjaro, this is the provider that lets you do it in one place.

How the pricing works

Corsica runs three tracks. On the compounded side, semaglutide is $149 month to month or $99 a month on a three-month plan paid upfront ($297), and tirzepatide is $299 month to month or $249 a month on a three-month plan ($747). The lowest numbers on the site hold only if you are willing to prepay for a quarter. Site banners also push a promo code for a further discount; we list the standing prices, not the coupon price.

The brand-name track is a flat figure across the lineup. Brand-name Ozempic, Wegovy, Mounjaro and Zepbound are all offered at the same monthly rate. That is a four-figure number, and it sits above each drug's list price and several times what Novo Nordisk and Eli Lilly charge in their own self-pay programs (roughly $299 to $699 a month). For comparison, the category median for monthly programs is $179. The compounded plans here sit in normal competitive territory. The brand option is, predictably, in a different universe of cost. The third track is a prescription-only service for Zepbound, Wegovy, the Wegovy pill and the Foundayo pill. Corsica charges an Rx service fee of $65 a month or $99 for 3 months and sends the prescription to LillyDirect or NovoCare. You pay the manufacturer for the medication separately.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

• Compounded semaglutide: $149 month to month, or $99/mo on the three-month plan
• Compounded tirzepatide: $299 month to month, or $249/mo on the three-month plan
• Prescription-only brand service: an Rx fee of $65 a month or $99 for 3 months; the medication is bought separately from LillyDirect or NovoCare
• Brand Ozempic, Wegovy, Mounjaro, Zepbound: $1,499 a month each, above list price and above the makers' own self-pay prices
• Every compounded and full brand plan includes the provider consultation, the medication if prescribed, shipping, and ongoing support

What's included, and how to get started

Corsica keeps the process to three steps: you complete an online assessment, a licensed provider reviews it, and if you are approved the medication ships to you. There is no separate menu of add-on fees buried in the flow: the company states that plans include a provider consultation, the medication itself when prescribed, free shipping, and ongoing care support. It advertises no-insurance-needed enrollment, free shipping on every order, and cancel-anytime terms. That is a clean, low-friction setup, and the shipping and consult are part of the standing price, not a teaser.

Prices you can see before intake

Plenty of providers claim to be transparent. Corsica is one of the few that backs it up by publishing every SKU, compounded and brand, in the open. The product cards carry dollar figures, which beats the many telehealth sites that hide the price behind a quiz. The platform also carries LegitScript certification, an independent check that the pharmacy operation meets legal and safety standards. In a category full of fly-by-night sellers, that's a reassuring baseline.

Where Corsica is frustratingly vague

For all its pricing openness, Corsica is oddly quiet about who it is. The legal entity name and state of incorporation are not disclosed on the site. By contrast, RxPros publishes its LLC name and a Wyoming business address. The compounding pharmacy that makes your semaglutide or tirzepatide is described only as a 'licensed compounding pharmacy' and is never named. So you cannot independently check that pharmacy's accreditation or inspection history, the way you can with providers that name their 503A or 503B partner outright. The company lists a New York City contact. It does not publish which states it ships to, so confirm your own state is covered during intake.

• Legal entity and state of incorporation are not published
• The compounding pharmacy partner is unnamed
• Per-state availability is not listed, so confirm your state during signup
• Promo-code banners advertise lower prices than the standing plan rates, so check what you will pay after any coupon expires
• Lab-work requirements aren't clearly spelled out before you enroll
• An internal site inconsistency exists: the homepage FAQ quotes a $149 starting price while the product cards start at $99 a month on a three-month plan, so confirm the plan and term at checkout

Who should choose Corsica, and who should skip it

Corsica is a strong fit if you specifically want to weigh a compounded plan against the brand pen and make that decision with the numbers in front of you. It is also reasonable if you want one provider that can serve you either way over time: start compounded to manage cost, then switch to brand later if you choose. The bundled shipping, included consult, and LegitScript certification make it a credible mainstream option rather than a bargain-bin one.

Skip it if pharmacy transparency is your top priority. If you want to know exactly which accredited pharmacy is compounding your medication and exactly what corporate entity stands behind the service, Corsica's refusal to name those things counts against it, and other providers disclose both. Trinity Meds, for example, names the 503A pharmacies that fill its orders. It is also not the move if you need confirmed coverage in your state before committing, since that information isn't posted. You can see how we weigh transparency, pricing, and safety in our scoring methodology.

Bottom line

Corsica Health earns its place on the strength of one uncommon thing: it shows you both the cheap compounded route and the brand route, openly priced, on a single platform with independent certification behind it. The compounded plans are competitively priced for shoppers willing to prepay a quarter, though the flat brand rate costs more than buying the same drugs through the makers' self-pay programs. The weakness is corporate and pharmacy opacity: Corsica tells you the price of everything while staying quiet about who it is and who fills your prescription. If transparent pricing is what you came for, it delivers. If you need to know the name on the pharmacy door, look elsewhere.